Sponsor pipeline

Genetix Biotherapeutics Inc. clinical trial pipeline

Get alerts when Genetix Biotherapeutics Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
1
Not charted: 5 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT04293185 A Study Evaluating Gene Therapy With BB305 Lentiviral Vector in Sickle Cell Disease Sickle Cell Disease Active, Not Recruiting 2024-12-10
Not specified
NCT06224413 A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With… Cerebral Adrenoleukodystrophy (CALD) Recruiting 2025-07-02
NCT06271512 A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel Beta-Thalassemia Recruiting 2025-02-11
NCT02698579 Long-term Follow-up of Participants With Cerebral Adrenoleukodystrophy Who Were Treated… Cerebral Adrenoleukodystrophy (CALD) Active, Not Recruiting 2026-09-14
NCT02633943 Long-term Follow-up of Subjects With Transfusion-Dependent β-Thalassemia (TDT) Treated… Transfusion-dependent Beta-Thalassemia Active, Not Recruiting 2025-04-09
NCT04628585 Long-term Follow-up of Subjects with Sickle Cell Disease Treated with Ex Vivo Gene Therapy Sickle Cell Disease Enrolling by Invitation 2025-03-20

Disease areas by active trials

Sickle Cell Disease (2) · Thalassemia (2)

Get alerts when Genetix Biotherapeutics Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free